NAGLAZYME CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/5ML
Product details
Registration number: SIN16831P
Classification: Prescription Only
Active ingredients: Galsulfase
Strength: 5mg/5ml
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Registrant: PHARM-D SINGAPORE PRIVATE LIMITED
ATC code: A16AB08
HSA approval date: 11 August 2023
Manufacturer(s): Vetter Pharma-Fertigung GmbH & Co. KG
Manufacturing country/countries: GERMANY
What are the HSA registration number and classification for NAGLAZYME CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/5ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16831P
Classification: Prescription Only
What active ingredients and strength are recorded for NAGLAZYME CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/5ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Galsulfase
Strength: 5mg/5ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for NAGLAZYME CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/5ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for NAGLAZYME CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/5ML?
According to the HSA dataset updated 7 August 2026:
Registrant: PHARM-D SINGAPORE PRIVATE LIMITED
Which manufacturers and countries are listed for NAGLAZYME CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/5ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Vetter Pharma-Fertigung GmbH & Co. KG
Manufacturing country/countries: GERMANY
Where can I look up NAGLAZYME CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/5ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16831P or the exact product name NAGLAZYME CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/5ML. The general register link does not preselect this product.
What are the source dates for this NAGLAZYME CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/5ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this NAGLAZYME CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/5ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16831P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)